Petros Pharmaceuticals, Inc. - stock earnings
PTPI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.5 million USD | 1.7 million USD |
| 2023Q2 | -2.5 million USD | 2.0 million USD |
| 2023Q1 | -219.4 million USD | 2.5 million USD |
| 2022Q4 | -4.2 million USD | 798101 USD |
| 2022Q3 | -13.8 million USD | -1.5 million USD |
| 2022Q2 | -2.0 million USD | 4.2 million USD |
| 2022Q1 | 3.5 million USD | 2.5 million USD |
| 2021Q4 | -8.2 million USD | -867160 USD |
| 2021Q3 | -1.7 million USD | 2.1 million USD |
| 2021Q2 | -2.1 million USD | 2.5 million USD |
| 2021Q1 | 3.0 million USD | 4.1 million USD |
| 2020Q4 | -5.4 million USD | 2.9 million USD |
| 2020Q3 | -3.3 million USD | 3.5 million USD |
| 2020Q2 | -5.8 million USD | 1.4 million USD |
| 2020Q1 | -6.1 million USD | 1.8 million USD |
PTPI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.7 million USD | 7.0 million USD |
| 2022 | -27.0 million USD | 6.0 million USD |
| 2021 | -9.4 million USD | 7.8 million USD |
| 2020 | -20.6 million USD | 9.6 million USD |
| 2019 | -32.5 million USD | 15.6 million USD |
PTPI
Price: $0.68
52 week price:
Earnings Per Share: -6.21 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 7800
Market Capitalization: 2.0 million